Evidence‑Based Recommendations for Tapering Escitalopram from 20 mg to 10 mg

Tapering Strategy

Comparative Discontinuation Profile

Monitoring During Taper

Pitfalls to Avoid

Reducing Escitalopram Dosage to Manage Negative Affect

Important Considerations for Dose Reduction

• Gradual reduction of escitalopram from 20mg to 10mg is recommended to minimize discontinuation symptoms, which can include dizziness, fatigue, lethargy, headaches, nausea, insomnia, and anxiety, as suggested by the American Academy of Child and Adolescent Psychiatry 2
• Abrupt discontinuation or too-rapid tapering can trigger discontinuation syndrome, particularly with shorter-acting SSRIs like escitalopram, according to the American Academy of Child and Adolescent Psychiatry 2
• It is crucial to distinguish between discontinuation symptoms and relapse of the underlying condition, as emphasized by the American Academy of Child and Adolescent Psychiatry 2